Development and validation of the functional assessment of cancer therapy–antiangiogenesis subscale

The Functional Assessment of Cancer Therapy (FACT)–Antiangiogenesis (AntiA) Subscale was developed and validated to enhance treatment decision-making and side effect management for patients receiving anti-angiogenesis therapies. Side effects related to anti-angiogenesis therapies were identified fro...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaiser, Karen, Beaumont, Jennifer L, Webster, Kimberly, Yount, Susan E, Wagner, Lynne I, Kuzel, Timothy M, Cella, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2015
Materias:
Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4430262/
https://www.ncbi.nlm.nih.gov/pubmed/25619758
http://dx.doi.org/10.1002/cam4.385

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4430262/
https://www.ncbi.nlm.nih.gov/pubmed/25619758
http://dx.doi.org/10.1002/cam4.385

Ejemplares similares